Literature DB >> 3757360

Skeletal metastases.

C S Galasko.   

Abstract

During the past ten to 20 years, there have been many advances in the understanding of the way in which skeletal metastases develop and great strides in the methods of detection, particularly with the development of the gamma camera and axial or whole-body skeletal scintigraphy. Skeletal metastases may present with pain, hypercalcemia, large lytic lesions, pathologic fracture, spinal cord or cauda equina compression, or spinal instability. Much has been learned about the management of skeletal metastases, and many of these developments have occurred in Great Britain.

Entities:  

Mesh:

Year:  1986        PMID: 3757360

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  17 in total

Review 1.  Comparative review of vertebroplasty and kyphoplasty.

Authors:  Fernando Ruiz Santiago; Alicia Santiago Chinchilla; Luis Guzmán Álvarez; Antonio Luis Pérez Abela; Maria Del Mar Castellano García; Miguel Pajares López
Journal:  World J Radiol       Date:  2014-06-28

2.  Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.

Authors:  M P Roudier; H Vesselle; L D True; C S Higano; S M Ott; S H King; R L Vessella
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  Imaging of skeletal metastases in myxoid liposarcoma.

Authors:  J L Noble; E Moskovic; C Fisher; I Judson
Journal:  Sarcoma       Date:  2010-03-30

4.  Breast cancer manifested by hematologic disorders.

Authors:  Takashi Ishikawa; Daisuke Shimizu; Ayako Kito; Ikuko Ota; Takeshi Sasaki; Mikiko Tanabe; Akimitsu Yamada; Hitoshi Arioka; Satoru Shimizu; Junichi Wakasugi; Ryutaro Mori; Takashi Chishima; Yasushi Ichikawa; Itaru Endo
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

5.  The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

Authors:  Mohsen Beheshti; Reza Vali; Peter Waldenberger; Friedrich Fitz; Michael Nader; Josef Hammer; Wolfgang Loidl; Christian Pirich; Ignac Fogelman; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2009 Nov-Dec       Impact factor: 3.488

6.  Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.

Authors:  Mohsen Beheshti; Reza Vali; Peter Waldenberger; Friedrich Fitz; Michael Nader; Wolfgang Loidl; Gabriele Broinger; Franz Stoiber; Ignac Foglman; Werner Langsteger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-09       Impact factor: 9.236

7.  Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome.

Authors:  Bill Ristevski; Richard J Jenkinson; David J G Stephen; Joel Finkelstein; Emil H Schemitsch; Michael D McKee; Hans J Kreder
Journal:  Can J Surg       Date:  2009-08       Impact factor: 2.089

8.  The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

Authors:  Mohsen Beheshti; Reza Vali; Peter Waldenberger; Friedrich Fitz; Michael Nader; Josef Hammer; Wolfgang Loidl; Christian Pirich; Ignac Fogelman; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2009-07-09       Impact factor: 3.488

9.  Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.

Authors:  Mehmet Halit Yilmaz; Mustafa Ozguroglu; Devrim Mert; Hande Turna; Gökhan Demir; Ibrahim Adaletli; Sila Ulus; Metin Halac; Kaya Kanberoğlu
Journal:  Med Oncol       Date:  2007-11-27       Impact factor: 3.064

10.  Full-length radiographs of the femur in patients with a femoral neck fracture and co-existent malignancy--are they of benefit?

Authors:  Maurice T O'Flaherty; Neville W Thompson; Peter K Ellis; R John Barr
Journal:  Ulster Med J       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.